Last reviewed · How we verify
NCT05794594
3D Printed Personalized Extendable Prosthesis
trial testing 3D printed personalized extendable prosthesis in Osteosarcoma in Children in 25 participants. Completed in 1 March 2023.
1 January 2023
Quick facts
| Lead sponsor | Yuxi Su |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 1 October 2015 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- 3D printed personalized extendable prosthesis
Conditions studied
- Osteosarcoma in Children — all drugs for Osteosarcoma in Children →
Sponsor
Yuxi Su
Who can join
Adults 6 to 18, any sex, with Osteosarcoma in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05794594
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Yuxi Su trials
Trials by the same sponsor.
- NCT05085509 — Foreign Body Removal With the Assistance of Ultrasound Guidance and Methylene Blue Staining in Children · NA · completed
- NCT04007016 — A New Pelvic Osteotomy Method for Open Reduction · completed
- NCT04425369 — Iliac Crest Bone Graft Harvesting for Pediatric Pelvic Osteotomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05794594 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuxi Su
- Last refreshed: 3 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05794594.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing